Bio Green Med Solution (BGMS) Operating Expenses (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Operating Expenses of $1.0 million for Q1 2026, down 75.7% year-over-year from $4.2 million in Q1 2025, and down 41.42% quarter-over-quarter from $1.7 million in Q4 2025.
Analysis
Bio Green Med Solution (BGMS) Operating Expenses (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Operating Expenses for 17 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 75.7% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $5.2 million (down 56.54% YoY), while the FY2025 annual figure was $9.2 million, down 23.85% from the prior year.
- Operating Expenses slipped to $1.0 million in Q1 2026 per BGMS's latest filing, from $1.7 million in the prior quarter.
- Across five years, Operating Expenses topped out at $8.8 million in Q4 2022 and bottomed at $1.0 million in Q1 2026.
- Historically, Operating Expenses has averaged $4.4 million across 5 years, with a median of $4.4 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses surged 52.36% — and 2026, when it sank 75.7%.
- Bio Green Med Solution's Operating Expenses stood at $8.8 million in 2022, then plunged by 39.05% to $5.4 million in 2023, then sank by 66.09% to $1.8 million in 2024, then dropped by 4.38% to $1.7 million in 2025, then tumbled by 41.42% to $1.0 million in 2026.
- Business Quant data shows BGMS's Operating Expenses at $1.0 million in Q1 2026, $1.7 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | -1.05 Bn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | 960.00 Mn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | 505.13 Mn |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 1.21 Bn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 541.02 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | 754,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 754,000.00 |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.25 Mn |
| Mar 31, 2025 | 4.21 Mn |
| Dec 31, 2024 | 1.83 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 3.65 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Dec 31, 2023 | 5.39 Mn |
| Sep 30, 2023 | 6.86 Mn |
| Jun 30, 2023 | 6.30 Mn |
| Mar 31, 2023 | 7.32 Mn |
| Dec 31, 2022 | 8.85 Mn |
| Sep 30, 2022 | 6.47 Mn |
| Jun 30, 2022 | 5.79 Mn |
| Mar 31, 2022 | 6.56 Mn |
| Dec 31, 2021 | 6.28 Mn |
| Sep 30, 2021 | 5.70 Mn |